1. Home
  2. CYTK vs SWKS Comparison

CYTK vs SWKS Comparison

Compare CYTK & SWKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$69.27

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Logo Skyworks Solutions Inc.

SWKS

Skyworks Solutions Inc.

HOLD

Current Price

$72.76

Market Cap

9.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
SWKS
Founded
1997
1962
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
9.0B
IPO Year
2004
1995

Fundamental Metrics

Financial Performance
Metric
CYTK
SWKS
Price
$69.27
$72.76
Analyst Decision
Strong Buy
Hold
Analyst Count
19
15
Target Price
$89.26
$70.38
AVG Volume (30 Days)
1.7M
4.7M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
4.53%
EPS Growth
N/A
N/A
EPS
N/A
0.76
Revenue
$13,368,000.00
$4,086,900,000.00
Revenue This Year
$7.37
N/A
Revenue Next Year
$310.19
$3.06
P/E Ratio
N/A
$92.49
Revenue Growth
N/A
N/A
52 Week Low
$31.99
$51.93
52 Week High
$80.20
$90.90

Technical Indicators

Market Signals
Indicator
CYTK
SWKS
Relative Strength Index (RSI) 45.21 49.83
Support Level $59.07 $70.45
Resistance Level $70.69 $74.83
Average True Range (ATR) 2.87 5.07
MACD -1.15 -1.29
Stochastic Oscillator 25.26 21.42

Price Performance

Historical Comparison
CYTK
SWKS

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About SWKS Skyworks Solutions Inc.

Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.

Share on Social Networks: